1-4 of 4
Cyrus Khan, MD
Close
Sort by
Journal Articles

Predictors and Long Term Outcomes for DLBCL Patients Undergoing Surgery Prior to Systemic Therapy

Thejus Jayakrishnan, MBBS, Yazan Samhouri, MD, Veli Bakalov, MD, Zena Chahine, MD, Rodney E Wegner, MD, Cyrus Khan, MD, Salman Fazal, MD, John Lister, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-137827
Published: 2020
Journal Articles

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study

Anas Younes, MD, John M Burke, MD, Bruce D. Cheson, MD, Catherine Diefenbach, MD, Silvia Ferrari, MD, Uwe H Hahn, MD, Eliza A Hawkes, Cyrus Khan, MD, Izidore S. Lossos, MD, Gerardo Musuraca, MD PhD, Monica Tani, Umberto Vitolo, Sam Lung Sang Yuen, MBBS,FRCPA,FRACP, Aparna Raval, PhD, Mahesh R. Shivhare, PhD, Tina G Nielsen, MD PhD, Gila Sellam, PhD, Jeff P. Sharman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2874.
https://doi.org/10.1182/blood-2019-123368
Published: 2019
Journal Articles

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL)

Parikshit Padhi, MD, Abhishek Chilkulwar, MD, Cyrus Khan, MD, Monank Patel, PharmD, BCOP, John Lister, MD, Xiaoqin Tang, PhD Director of Biostatistics
Journal: Blood
Blood (2016) 128 (22): 5410.
https://doi.org/10.1182/blood.V128.22.5410.5410
Published: 2016
Journal Articles

Induction Therapy with Dasatinib and Prednisone for Patients with Philadelphia Positive ALL

Abhishek Chilkulwar, MD, Salman Fazal, MD, Jocelyn T. De Yao, MD, Parik Padhi, MD, Cyrus Khan, MD, John Lister, MD
Journal: Blood
Blood (2015) 126 (23): 4907.
https://doi.org/10.1182/blood.V126.23.4907.4907
Published: 2015